Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Meilai Pharmaceutical Technology Co., Ltd. is a research-driven pharmaceutical company based in Chongqing, China, specializing in the development and manufacture of high-end pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Founded in 2012, the company focuses on complex organic synthesis and process optimization for therapeutic areas such as oncology, cardiovascular health, and antiviral treatments. Meilai Pharm operates as a contract research and manufacturing organization (CRO/CMO), providing custom synthesis and technical services to global pharmaceutical clients. The company maintains modern R&D laboratories and production facilities designed to meet international quality standards, supporting the supply chain for both generic and innovative drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Meilai Pharmaceutical.